跳至主要内容
临床试验/ISRCTN67937027
ISRCTN67937027已完成未知

Randomised Evaluation of Modified Valsalva Effectivness in Re-entrant Tachycardias (REVERT) study

Royal Devon and Exeter Foundation Trust (UK)0 个研究点目标入组 372 人开始时间: 2013年2月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
372

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18 years and over
  • 2. Stable male or female adult patients presenting to the Emergency Department with SVT (regular, narrow complex tachycardia with QRS duration <0.12ms on ECG)
  • 3. Written informed consent to participate

排除标准

  • 1. Unstable patient (BP < 90mmHg systolic or any indication for immediate drug or DC cardioversion)
  • 2. Atrial fibrillation or atrial flutter on ECG
  • 3. Suspected atrial flutter requiring a trial of adenosine
  • 4. Severe hypertension (systolic BP >220mmHg or diastolic >120mmHg)
  • 5. Any contraindication to or inability to performing a VM
  • 6. Contraindication or inability to lay flat or lift legs
  • 7. 3rd trimester pregnancy
  • 8. Patients without capacity to provide written informed consent
  • 9. Previous inclusion in the study

研究者

发起方
Royal Devon and Exeter Foundation Trust (UK)

相似试验